Differential role for CD277 as a co-regulator of the immune signal in T and NK cells

European Journal of Immunology

Volumn 41, Issue 12, 2011, Pages 3443-3454

  Messal, Nassima ^a,b,c   Mamessier, Emilie ^a,b,c,d   Sylvain, Aude ^a,b,c,e   Celis Gutierrez, Javier ^a,b,c   Thibult, Marie Laure ^a,b,c   Chetaille, Bruno ^a,b,c   Firaguay, Guylène ^a,b,c   Pastor, Sonia ^a,b,c   Guillaume, Yves ^a,b,c   Wang, Qian ^a,b,c   Hirsch, Ivan ^a,b,c   Nunès, Jacques A ^a,b,c   Olive, Daniel ^a,b,c  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Butyrophilin; Cell activation; Co stimulatory molecules; T cells

Indexed keywords

B7 ANTIGEN; BUTYROPHILIN 3A1; BUTYROPHILIN 3A2; BUTYROPHILIN 3A3; CD16 ANTIGEN; CD277 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN ISOFORMS; RECEPTORS, ANTIGEN, T-CELL; UP-REGULATION;

EID: 82255164220     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141404     Document Type: Article

References (27)

1. Compte, E., Pontarotti, P., Collette, Y., Lopez, M. and Olive, D., Frontline: characterization of BT3 molecules belonging to the B7 family expressed on immune cells. Eur. J. Immunol. 2004. 34: 2089-2099.
2. Henry, J., Ribouchon, M., Depetris, D., Mattei, M., Offer, C., Tazi-Ahnini, R. and Pontarotti, P., Cloning, structural analysis, and mapping of the B30 and B7 multigenic families to the major histocompatibility complex (MHC) and other chromosomal regions. Immunogenetics 1997. 46: 383-395.
3. Tazi-Ahnini, R., Henry, J., Offer, C., Bouissou-Bouchouata, C., Mather, I. H. and Pontarotti, P., Cloning, localization, and structure of new members of the butyrophilin gene family in the juxta-telomeric region of the major histocompatibility complex. Immunogenetics 1997. 47: 55-63.
4. Henry, J., Ribouchon, M. T., Offer, C. and Pontarotti, P., B30.2-like domain proteins: a growing family. Biochem. Biophys. Res. Commun. 1997. 235: 162-165.
5. Rhodes, D. A., Stammers, M., Malcherek, G., Beck, S. and Trowsdale, J., The cluster of BTN genes in the extended major histocompatibility complex. Genomics 2001. 71: 351-362.
6. Ogg, S. L., Weldon, A. K., Dobbie, L., Smith, A. J. and Mather, I. H., Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc. Natl. Acad. Sci. USA 2004. 101: 10084-10089.
7. Robenek, H., Hofnagel, O., Buers, I., Lorkowski, S., Schnoor, M., Robenek, M. J., Heid, H. et al., Butyrophilin controls milk fat globule secretion. Proc. Natl. Acad. Sci. USA 2006. 103: 10385-10390.
8. Ishii, T., Aoki, N., Noda, A., Adachi, T., Nakamura, R. and Matsuda, T., Carboxy-terminal cytoplasmic domain of mouse butyrophilin specifically associates with a 150-kDa protein of mammary epithelial cells and milk fat globule membrane. Biochim. Biophys. Acta 1995. 1245: 285-292.
9. Henry, J., Mather, I. H., McDermott, M. F. and Pontarotti, P., B30.2-like domain proteins: update and new insights into a rapidly expanding family of proteins. Mol. Biol. Evol. 1998. 15: 1696-1705.
10. Malcherek, G., Mayr, L., Roda-Navarro, P., placeRhodes, D., Miller, N. and Trowsdale, J., The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN. J. Immunol. 2007. 179: 3804-3811.
11. Nguyen, T., Liu, X. K., Zhang, Y. and Dong, C., BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 2006. 176: 7354-7360.
12. Arnett, H. A., Escobar, S. S., Gonzalez-Suarez, E., Budelsky, A. L., Steffen, L. A., Boiani, N., Zhang, M. et al., BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 2007. 178: 1523-1533.
13. Yamashiro, H., Yoshizaki, S., Tadaki, T., Egawa, K. and Seo, N., Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity. J. Leukoc. Biol. 2010. 88: 757-767.
14. Acuto, O. and Cantrell, D., T cell activation and the cytoskeleton. Annu. Rev. Immunol. 2000. 18: 165-184.
15. Appleman, L. J., van Puijenbroek, A. A., Shu, K. M., Nadler, L. M. and Boussiotis, V. A., CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 2002. 168: 2729-2736.
16. Serriari, N. E., Gondois-Rey, F., Guillaume, Y., Remmerswaal, E. B., Pastor, S., Messal, N., Truneh, A. et al., B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 2010. 185: 3140-3148.
17. + T cells in the absence of exogenous feeder cells. J. Immunol. 1997. 159: 5921-5930.
18. Simone, R., Barbarat, B., Rabellino, A., Icardi, G., Bagnasco, M., Pesce, G., Olive, D. and Saverino, D., Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. Mol. Immunol. 2010. 48: 109-118.
19. Cubillos-Ruiz, J. R., Martinez, D., Scarlett, U. K., Rutkowski, M. R., Nesbeth, Y. C., Camposeco-Jacobs, A. L. and Conejo-Garcia, J. R., CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget 2010. 1: 329-338.
20. Stremlau, M., Perron, M., Welikala, S. and Sodroski, J., Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005. 79: 3139-3145.
21. Jeong, J., Rao, A. U., Xu, J., Ogg, S. L., Hathout, Y., Fenselau, C. and Mather, I. H., The PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase: implications for the function of BTN1A1 in the mammary gland and other tissues. J. Biol. Chem. 2009. 284: 22444-22456.
22. Smith, I. A., Knezevic, B. R., Ammann, J. U., Rhodes, D. A., Aw, D., Palmer, D. B., Mather, I. H. and Trowsdale, J., BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 2010. 184: 3514-3525.
23. Nunes, J., Klasen, S., Ragueneau, M., Pavon, C., Couez, D., Mawas, C., Bagnasco, M. and Olive, D., CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 1993. 5: 311-315.
24. Ghiotto, M., Gauthier, L., Serriari, N., Pastor, S., Truneh, A., Nunes, J. A. and Olive, D., PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int. Immunol. 2010. 22: 651-660.
25. Yagita, M., Huang, C. L., Umehara, H., Matsuo, Y., Tabata, R., Miyake, M., Konaka, Y. and Takatsuki, K., A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000. 14: 922-930.
26. Sharp, A. J., Hansen, S., Selzer, R. R., Cheng, Z., Regan, R., Hurst, J. A., Stewart, H. et al., Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 2006. 38: 1038-1042.
27. Firaguay, G. and Nunes, J. A., Analysis of signaling events by dynamic phosphoflow cytometry. Sci. Signal. 2009. 86: 13.